Efficacy of HIPEC in Patients With Colorectal Cancer at High Risk of Peritoneal Carcinomatosis
A Multicenter Prospective Randomized Controlled Clinical Trial of Hyperthermic Intraperitoneal Chemotherapy After Colectomy in Patients With Colorectal Cancer at High Risk of Peritoneal Carcinomatosis
Sponsor: Affiliated Cancer Hospital & Institute of Guangzhou Medical University
This PHASE3 trial investigates Colorectal Cancer and is currently actively recruiting participants. Affiliated Cancer Hospital & Institute of Guangzhou Medical University leads this study, which shows 11 recorded versions since 2020 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Recruiting PHASE3
-
Aug 2025 — Sep 2025 [monthly]
Recruiting PHASE3
-
Jun 2025 — Aug 2025 [monthly]
Recruiting PHASE3
-
Sep 2024 — Jun 2025 [monthly]
Recruiting PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE3
▶ Show 6 earlier versions
-
Jul 2023 — Jul 2024 [monthly]
Recruiting PHASE3
-
Nov 2022 — Jul 2023 [monthly]
Recruiting PHASE3
-
Jan 2021 — Nov 2022 [monthly]
Recruiting PHASE3
-
Sep 2020 — Jan 2021 [monthly]
Recruiting PHASE3
-
Jul 2020 — Sep 2020 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Jun 2020 — Jul 2020 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Affiliated Cancer Hospital & Institute of Guangzhou Medical University
- Beijing Hospital
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Chongqing University Cancer Hospital
- First Affiliated Hospital of Chongqing Medical University
- First Affiliated Hospital, Sun Yat-Sen University
- First People's Hospital of Foshan
- Fudan University
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Guangdong Provincial People's Hospital
- Hebei Medical University Fourth Hospital
- Jiangmen Central Hospital
- Meizhou People's Hospital
- Nanfang Hospital, Southern Medical University
- Peking University Cancer Hospital & Institute
- Peking University People's Hospital
- People's Hospital of Deyang City
- People's Hospital of Guangxi Zhuang Autonomous Region
- Renmin Hospital of Wuhan University
- Second Affiliated Hospital, School of Medicine, Zhejiang University
- Shantou Central Hospital
- Shenzhen Second People's Hospital
- Sichuan Provincial People's Hospital
- Sixth Affiliated Hospital, Sun Yat-sen University
- Sun Yat-sen University
- The Affiliated Hospital Of Southwest Medical University
- The Affiliated Hospital of Xuzhou Medical University
- The Affiliated Tumor Hospital of Guangxi Medical University
- The First Affiliated Hospital of Nanchang University
- The People's Hospital of Leshan
- The Second Affiliated Hospital of Chongqing Medical University
- The Third People's Hospital of Chengdu
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- West China Hospital
- Wuhan University
- Zhongshan People's Hospital, Guangdong, China
- ZhuHai Hospital
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Beijing, China , Chengdu, China , Chongqing, China , Deyang, China , Foshan, China , Guangzhou, China , Hangzhou, China , Jiangmen, China , Leshan, China , Luzhou, China and 11 more locations